TPG GP A, LLC 13D/13G Filings for Fusion Pharmaceuticals Inc. (FUSN)

TPG GP A, LLC 13D and 13G filings for Fusion Pharmaceuticals Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2022-01-18
5:30 pm
Purchase
2022-01-12 13D Fusion Pharmaceuticals Inc.
FUSN
TPG GP A, LLC 2,621,436
6.100%
2,621,436increase
(New Position)
Filing